Menu Search
Equities

Vivione Biosciences Inc

VBI.H:NEX

Vivione Biosciences Inc

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 16 2017.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Vivione Biosciences Inc's net income fell 54.97% from a loss of 85.24k to a larger loss of 132.10k despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-85.04%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2017, Vivione Biosciences Inc increased its cash reserves by 563.79%, or 3.27k. Cash Flow from Financing totalled 7.29k or -- of revenues. In addition the company used 4.02k for operations while cash used for investing totalled .
Cash flow per share--
Price/Cash flow per share--
Book value per share-0.0052
Tangible book value per share-0.0052
More ▼

Balance sheet in USDView more

Vivione Biosciences Inc uses little or no debt in its capital structure.
Current ratio0.0056
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.